African ancestry is a predictor factor to secondary progression in clinical course of multiple sclerosis.

ISRN Neurology Pub Date : 2012-01-01 DOI:10.5402/2012/410629
Claudia Cristina Ferreira Vasconcelos, Gutemberg Augusto Cruz Dos Santos, Luiz Claudio Thuler, Solange Maria Camargo, Regina Maria Papais Alvarenga
{"title":"African ancestry is a predictor factor to secondary progression in clinical course of multiple sclerosis.","authors":"Claudia Cristina Ferreira Vasconcelos,&nbsp;Gutemberg Augusto Cruz Dos Santos,&nbsp;Luiz Claudio Thuler,&nbsp;Solange Maria Camargo,&nbsp;Regina Maria Papais Alvarenga","doi":"10.5402/2012/410629","DOIUrl":null,"url":null,"abstract":"<p><p>Background. Studies on the clinical course of multiple sclerosis have indicated that certain initial clinical factors are predictive of disease progression. Regions with a low prevalence for disease, which have environmental and genetic factors that differ from areas of high prevalence, lack studies on the progressive course and disabling characteristics of the disease. Objective. To analyse the long-term evolution to the progressive phase of the relapsing-remitting multiple sclerosis and its prognosis factors in mixed population. Methods. We performed a survival study and logistic regression to examine the influence of demographic and initial clinical factors on disease progression. Among 553 relapsing-remitting patients assisted at a Brazilian reference centre for multiple sclerosis, we reviewed the medical records of 150 patients who had a disease for ten or more years. Results. African ancestry was a factor that conferred more risk for secondary progression followed by age at the onset of the disease and the number of relapses in the year after diagnosis. A greater understanding of the influence of ancestry on prognosis serves to stimulate genetics and pharmacogenomics research and may clarify the poorly understood neurodegenerative progression of MS.</p>","PeriodicalId":14626,"journal":{"name":"ISRN Neurology","volume":"2012 ","pages":"410629"},"PeriodicalIF":0.0000,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2012/410629","citationCount":"20","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ISRN Neurology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5402/2012/410629","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 20

Abstract

Background. Studies on the clinical course of multiple sclerosis have indicated that certain initial clinical factors are predictive of disease progression. Regions with a low prevalence for disease, which have environmental and genetic factors that differ from areas of high prevalence, lack studies on the progressive course and disabling characteristics of the disease. Objective. To analyse the long-term evolution to the progressive phase of the relapsing-remitting multiple sclerosis and its prognosis factors in mixed population. Methods. We performed a survival study and logistic regression to examine the influence of demographic and initial clinical factors on disease progression. Among 553 relapsing-remitting patients assisted at a Brazilian reference centre for multiple sclerosis, we reviewed the medical records of 150 patients who had a disease for ten or more years. Results. African ancestry was a factor that conferred more risk for secondary progression followed by age at the onset of the disease and the number of relapses in the year after diagnosis. A greater understanding of the influence of ancestry on prognosis serves to stimulate genetics and pharmacogenomics research and may clarify the poorly understood neurodegenerative progression of MS.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
非洲血统是多发性硬化症临床过程中继发性进展的预测因素。
背景。对多发性硬化症临床病程的研究表明,某些初始临床因素可预测疾病进展。疾病低流行地区的环境和遗传因素与高流行地区不同,缺乏对疾病进展过程和致残特征的研究。目标。分析混合人群复发缓解型多发性硬化症向进展期的长期演变及其预后因素。方法。我们进行了一项生存研究和逻辑回归,以检验人口统计学和初始临床因素对疾病进展的影响。在巴西多发性硬化症参考中心接受治疗的553名复发缓解型患者中,我们回顾了150名患病10年或以上的患者的医疗记录。结果。非洲血统是继发性进展风险较高的一个因素,其次是发病年龄和诊断后一年内复发次数。更好地了解祖先对预后的影响有助于促进遗传学和药物基因组学研究,并可能阐明尚不清楚的多发性硬化症神经退行性进展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Small fiber neuropathy associated with hyperlipidemia: utility of cutaneous silent periods and autonomic tests. Cognitive impairment in relapsing remitting and secondary progressive multiple sclerosis patients: efficacy of a computerized cognitive screening battery. Minimizing technical failure of percutaneous balloon compression for trigeminal neuralgia using neuronavigation. Nonmotor symptoms in early- and advanced-stage Parkinson's disease patients on dopaminergic therapy: how do they correlate with quality of life? Evaluating different aspects of prospective memory in amnestic and nonamnestic mild cognitive impairment.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1